Your carefully designed clinical budget is already deviating from your plan. Worse yet, you may have protocol and operational changes that require changes in scope. With the upcoming budget season Senior Management wants a reforecast of existing studies and a budget estimate for new ones, starting later in the year or in 2023. With no time, a lean team, and lack of industry costing intelligence, how will you manage these challenges? Clinical Maestro® PORTFOLIO enables you to develop a budget or create "what if analyses" and understand impact to budget and timelines with the push of a button. Increase staff morale by decreasing their effort by and accelerate your turnaround with rapid study modeling which is more than 95% accurate. Leading biopharmaceutical sponsors trust PORTFOLIO for pipeline planning and budgeting with superior results and reported more than 10x Return on Investment.

Strengthen your processes and increase data-driven decision-making for faster study start-ups.
Strengthen your processes and increase data-driven decision-making for faster study start-ups.
RESOURCES
Explore Expert Insights and Resources for Clinical Excellence

Webinars
CRO budgets: complex, time-consuming, and often a black box. But they don’t have to be. Join us for a high-impact session where Leslie Mathews, Anca Copaescu, and Andrei Antonescu walk you through the real-world mechanics of CRO budgeting—from decoding activity grids to pressure-testing your numbers with powerful benchmarks.

Blogs
Effective vendor governance is essential to ensure operational success, cost efficiency, and regulatory compliance. Learn more here in our blog!

Case Studies
Faced with inefficiencies, compliance risks, and fragmented communication, a biopharma company dramatically enhanced its vendor governance by implementing VISION!
DEMO
Request a demo
Discover how Strategikon’s advanced solutions can streamline your clinical trial operations. Request a personalized demo to explore how our tools transform budgeting, vendor management, and outsourcing efficiency for pharma and biotech.